Literature DB >> 15982446

Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers.

Seog Ju Kim1, In Kyoon Lyoo, Jaeuk Hwang, Ain Chung, Young Hoon Sung, Jihyun Kim, Do-Hoon Kwon, Kee Hyun Chang, Perry F Renshaw.   

Abstract

Authors explored grey-matter density in 29 methamphetamine abusers and 20 healthy comparison subjects using voxel-based morphometry. Grey-matter density changes and performances on the Wisconsin Card Sorting test (WCST) were also compared between 11 short-term (<6 months) and 18 long-term (>or=6 months) abstinent methamphetamine abusers. Methamphetamine abusers had lower grey-matter density in the right middle frontal cortex (corrected p<0.05) and more total errors in the WCST (p<0.01) relative to healthy comparison subjects. Grey-matter density decrease in the right middle frontal cortex correlated with total errors in the WCST in methamphetamine abusers (r=-0.45). Long-term abstinent abusers had significantly less right middle frontal grey-matter density decrease (p<0.01) and total errors in the WCST (p<0.01) than short-term abstinent abusers, but more than the healthy comparison subjects. We report that methamphetamine abusers have prefrontal grey-matter deficit, which may, in part, recover with long-term abstinence.

Entities:  

Mesh:

Year:  2005        PMID: 15982446     DOI: 10.1017/S1461145705005699

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  59 in total

1.  Effect of methamphetamine dependence on heart rate variability.

Authors:  Brook L Henry; Arpi Minassian; William Perry
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

2.  Prefrontal and temporal gray matter density decreases in opiate dependence.

Authors:  In Kyoon Lyoo; Mark H Pollack; Marisa M Silveri; Kyung Heup Ahn; Claudia I Diaz; Jaeuk Hwang; Seog Ju Kim; Deborah A Yurgelun-Todd; Marc J Kaufman; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-12-21       Impact factor: 4.530

3.  Predisposition to and effects of methamphetamine use on the adolescent brain.

Authors:  I K Lyoo; S Yoon; T S Kim; S M Lim; Y Choi; J E Kim; J Hwang; H S Jeong; H B Cho; Y A Chung; P F Renshaw
Journal:  Mol Psychiatry       Date:  2015-02-10       Impact factor: 15.992

Review 4.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

5.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

6.  Repeated co-administrations of alcohol- and methamphetamine-produced anxiogenic effect could be associated with the neurotoxicity in the dentate gyrus.

Authors:  Jia-Ying Chuang; Wan-Ting Chang; Chianfang G Cherng; Gour-Shenq Kao; Lung Yu
Journal:  J Neural Transm (Vienna)       Date:  2011-04-17       Impact factor: 3.575

Review 7.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 8.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

Review 9.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users.

Authors:  Daniel Alicata; Linda Chang; Christine Cloak; Kylie Abe; Thomas Ernst
Journal:  Psychiatry Res       Date:  2009-09-26       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.